Worldclass care for underserved health markets
We are developing technology that applies Artificial Intelligence and novel protocols in Biomarker detection for this purpose, with a founding team of well credentialed and highly motivated biomedical science researchers who hail from Nigeria and Bangladesh and have received postgraduate degrees from the Universities of Cambridge, Manchester and Ilorin. Our research experience includes rapid diagnostic device development for tuberculosis, cost effective methods of sex chromosome anomaly detection (for Swyer syndrome) and the use of AI in improving detection of early-onset triple-negative breast cancer (TNBC).
Our pioneer product is targeted at maternal care sector of healthcare. We have invented a diagnostic device that facilitates early detection of biological conditions that may cause miscarriages and preterm births (colloquially called premature births), thus, giving pregnant women a chance at preventing it.
The A Team
Mkpouto Udo Pius
Chief Executive Officer
Chief Operations Officer
Chief Technology Officer
News & Event
Biomasys Chief Technology Officer Nusrat Rouf discuses HealtiPreg and potential collaboration with governments to combat maternal mortality.
Biomasys accepted into the prestigious Accelerate programme at the University of Cambridge.
Biomasys co-founder recognised as one of the top 10 promising entrepreneurs in Bangladesh.
Dear healthcare administrator Do you use maximon? What do you love most about the software? #healthcare #biomasys https://t.co/P8kQ9RWQEwRead More
Go out there and crush your goals! Happy Monday 😀 #biomasys #monday https://t.co/g8pMsjhbD0Read More
Scared of taking that big step? Do it scared! #biomasys #motivation https://t.co/nmKgpOrk8ZRead More
Healthcare management in today's world faces lots of problems. Here are the top 4 problems of healthcare. #management #healthcare #biomasys https://t.co/HAXBcIhbP0Read More